HER2 Support Group Forums - View Single Post

madubois63 · 10-12-2006, 05:28 PM

HERE'S ANOTHER ONE I JUST GOT TODAY...

At some point in the past you used the NexProfiler Treatment Option Tool for Breast Cancer. At the time you registered for this treatment decision tool, you indicated that you would be interested in being contacted by NexCura, which operates the NexProfiler Tool for Cancer, for opportunities to participate in market research.

We recognize that dealing with breast cancer can be a difficult experience and that you may not want to participate in market research. If that is the case, please delete this e-mail.

We are writing to let you know that a research group will be conducting phone interviews with breast cancer patients between October 25th and November 3rd. The research group is offering $75 to patients who qualify and participate in a 45-minute phone interview.

In order to participate in these interviews, you must meet ONE of the following criteria:

Be a breast cancer patient who is currently being treated with Abraxane
OR
Be a breast cancer patient who has discontinued treatment with Abraxane
OR
Be a breast cancer patient who is currently being treated a with chemotherapy other than Abraxane

There are additional criteria required for participation. In order to see if you qualify, we invite you to take a brief pre-screening survey (approximately 9 questions) by clicking here.

If the link doesn't work, please paste the following url into your browser:
https://survey.nexcura.com/Survey.as...e-4bd83f455a05

Any one of these questions may disqualify you from participation, but you may be asked all 9 questions before finding out if you qualify to participate in the phone interview. All of the data collected (if qualified) will be passed over to the market research group hosting the study. If you qualify, the market research group will contact you to schedule the interview.

This study is strictly for research purposes.

Participation in these research interviews is limited and there may be additional criteria needed to participate. If you wish to share this opportunity with others who may be eligible in your area, please forward this message to them.

Questions about this research?
You may contact us at:

Patient Information Services
NexCura, A Thomson Business
1725 Westlake Ave. N., Suite 300
Seattle, WA 98109

E-mail: interviews@education.nexcura.com
Phone: 1-877-422-3228

If you wish to review NexCura's Privacy Statement, visit:
http://www.nexcura.com/nexcura/Nexcura_Privacy.asp

10-12-2006, 05:28 PM	#2
madubois63 Senior Member Join Date: Feb 2005 Location: LI, NY Posts: 660	HERE'S ANOTHER ONE I JUST GOT TODAY... At some point in the past you used the NexProfiler Treatment Option Tool for Breast Cancer. At the time you registered for this treatment decision tool, you indicated that you would be interested in being contacted by NexCura, which operates the NexProfiler Tool for Cancer, for opportunities to participate in market research. We recognize that dealing with breast cancer can be a difficult experience and that you may not want to participate in market research. If that is the case, please delete this e-mail. We are writing to let you know that a research group will be conducting phone interviews with breast cancer patients between October 25th and November 3rd. The research group is offering $75 to patients who qualify and participate in a 45-minute phone interview. In order to participate in these interviews, you must meet ONE of the following criteria: Be a breast cancer patient who is currently being treated with Abraxane OR Be a breast cancer patient who has discontinued treatment with Abraxane OR Be a breast cancer patient who is currently being treated a with chemotherapy other than Abraxane There are additional criteria required for participation. In order to see if you qualify, we invite you to take a brief pre-screening survey (approximately 9 questions) by clicking here. If the link doesn't work, please paste the following url into your browser: https://survey.nexcura.com/Survey.as...e-4bd83f455a05 Any one of these questions may disqualify you from participation, but you may be asked all 9 questions before finding out if you qualify to participate in the phone interview. All of the data collected (if qualified) will be passed over to the market research group hosting the study. If you qualify, the market research group will contact you to schedule the interview. This study is strictly for research purposes. Participation in these research interviews is limited and there may be additional criteria needed to participate. If you wish to share this opportunity with others who may be eligible in your area, please forward this message to them. Questions about this research? You may contact us at: Patient Information Services NexCura, A Thomson Business 1725 Westlake Ave. N., Suite 300 Seattle, WA 98109 E-mail: interviews@education.nexcura.com Phone: 1-877-422-3228 If you wish to review NexCura's Privacy Statement, visit: http://www.nexcura.com/nexcura/Nexcura_Privacy.asp __________________ Maryann Stage IV Inflammatory BC 1/00 Mod Rad Mastectomy 24nod/5+ Adriomycin Cytoxin Taxol Tamoxifen 4 1/2 yrs Radiation - 32 x Metastatic BC lung/liver 10/04 thorocentesis 2x - pleurodesis Herceptin Taxatiere Carbo Femera/Lupron BC NED 4/05 chemo induced Acute Myeloid Leukemia 5/06 Induction/consolidation chemo bone marrow transplant - 11/3/06 Severe Host vs Graft Disease of liver BC mets to lung 11/07 Fasoladex Herceptin Zometa Xeloda GVHD/Iron overload to liver Avascular Necrosis/morphine pump 10/10 metastatic brain tumor steriotactic radiosurgery